Robert Zangerle

7.7k total citations
81 papers, 2.4k citations indexed

About

Robert Zangerle is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Robert Zangerle has authored 81 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Infectious Diseases, 38 papers in Virology and 34 papers in Epidemiology. Recurrent topics in Robert Zangerle's work include HIV Research and Treatment (38 papers), HIV/AIDS drug development and treatment (25 papers) and HIV/AIDS Research and Interventions (22 papers). Robert Zangerle is often cited by papers focused on HIV Research and Treatment (38 papers), HIV/AIDS drug development and treatment (25 papers) and HIV/AIDS Research and Interventions (22 papers). Robert Zangerle collaborates with scholars based in Austria, Switzerland and Spain. Robert Zangerle's co-authors include Dietmar Fuchs, Mario Sarcletti, H. Wächter, Gernot P. Tilz, Hans Winkler, Reiner Fischer‐Colbrie, Helmut Wächter, Antonio Diez‐Ruiz, Gabriele Baier‐Bitterlich and Peter Fritsch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Robert Zangerle

79 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Zangerle Austria	29	851	833	698	378	377	81	2.4k
Alex Lund Laursen Denmark	28	1.1k 1.3×	1.0k 1.3×	635 0.9×	171 0.5×	314 0.8×	125	2.5k
Lena Al‐Harthi United States	37	783 0.9×	614 0.7×	1.6k 2.2×	710 1.9×	358 0.9×	113	3.3k
Cecilia M. Shikuma United States	35	2.3k 2.7×	959 1.2×	2.0k 2.9×	344 0.9×	1.8k 4.7×	156	4.2k
Hélène C. F. Côté Canada	33	1.0k 1.2×	603 0.7×	792 1.1×	686 1.8×	915 2.4×	113	3.3k
Norbert H. Brockmeyer Germany	32	798 0.9×	1.2k 1.4×	450 0.6×	461 1.2×	430 1.1×	162	3.3k
Monty Montano United States	24	819 1.0×	390 0.5×	949 1.4×	740 2.0×	168 0.4×	66	2.5k
Jeff E. Mold Sweden	25	398 0.5×	470 0.6×	578 0.8×	841 2.2×	165 0.4×	41	3.8k
Angélique Biancotto United States	33	446 0.5×	572 0.7×	633 0.9×	922 2.4×	121 0.3×	84	4.0k
Tricia H. Burdo United States	35	1.5k 1.7×	866 1.0×	2.6k 3.8×	627 1.7×	2.1k 5.5×	129	4.8k
Maurice R.G. O’Gorman United States	31	629 0.7×	473 0.6×	533 0.8×	592 1.6×	137 0.4×	104	2.7k

Countries citing papers authored by Robert Zangerle

Since Specialization

Citations

This map shows the geographic impact of Robert Zangerle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Zangerle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Zangerle more than expected).

Fields of papers citing papers by Robert Zangerle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Zangerle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Zangerle. The network helps show where Robert Zangerle may publish in the future.

Co-authorship network of co-authors of Robert Zangerle

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Zangerle. A scholar is included among the top collaborators of Robert Zangerle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Zangerle. Robert Zangerle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Notter, Julia, Hansjakob Furrer, Matthias Hoffmann, et al.. (2025). Machine Learning-based Prediction of Active Tuberculosis in People With HIV Using Clinical Data. Clinical Infectious Diseases. 81(3). 521–530. 2 indexed citations

Trickey, Adam, Robert Glaubius, Nikos Pantazis, et al.. (2024). Estimation of Improvements in Mortality in Spectrum Among Adults With HIV Receiving Antiretroviral Therapy in High-Income Countries. JAIDS Journal of Acquired Immune Deficiency Syndromes. 95(1S). e89–e96. 5 indexed citations

Olson, Ashley, Norbert Bannert, Anders Sönnerborg, et al.. (2017). Temporal trends of transmitted HIV drug resistance in a multinational seroconversion cohort. AIDS. 32(2). 161–169. 20 indexed citations

Lodi, Sara, Martin Fisher, Andrea De Luca, et al.. (2013). Symptomatic Illness and Low CD4 Cell Count at HIV Seroconversion as Markers of Severe Primary HIV Infection. PLoS ONE. 8(11). e78642–e78642. 9 indexed citations

Mandorfer, Mattias, Karin Neukam, Thomas Reiberger, et al.. (2013). The impact of interleukin 28B rs12979860 single nucleotide polymorphism and liver fibrosis stage on response-guided therapy in HIV/HCV-coinfected patients. AIDS. 27(17). 2707–2714. 9 indexed citations

Zangerle, Robert, Katharina Kurz, Gabriele Neurauter, et al.. (2009). Increased blood phenylalanine to tyrosine ratio in HIV-1 infection and correction following effective antiretroviral therapy. Brain Behavior and Immunity. 24(3). 403–408. 75 indexed citations

Asten, Liselotte van, Robert Zangerle, Ildefonso Hernández‐Aguado, et al.. (2005). Do HIV Disease Progression and HAART Response Vary among Injecting Drug Users in Europe?. European Journal of Epidemiology. 20(9). 795–804. 9 indexed citations

Höpfl, Reinhard, et al.. (2003). High prevalence of high risk human papillomavirus-capsid antibodies in human immunodeficiency virus-seropositive men: a serological study. BMC Infectious Diseases. 3(1). 6–6. 7 indexed citations

Zangerle, Robert, et al.. (2002). Effective Antiretroviral Therapy Reduces Degradation of Tryptophan in Patients with HIV-1 Infection. Clinical Immunology. 104(3). 242–247. 72 indexed citations

10.

Zangerle, Robert, et al.. (1999). Persistent Flank Pain, Low-Grade Fever, and Malaise in a Woman Treated with Indinavir. AIDS Patient Care and STDs. 13(2). 81–87. 3 indexed citations

11.

Prins, M., Roy Robertson, R.P. Brettle, et al.. (1999). Do gender differences in CD4 cell counts matter?. AIDS. 13(17). 2361–2364. 106 indexed citations

12.

Baier, Gottfried, Dietmar Fuchs, Robert Zangerle, et al.. (1997). trans -Activation of the HIV Type 1 Promoter by 7,8-Dihydroneopterin in Vitro. AIDS Research and Human Retroviruses. 13(2). 173–178. 14 indexed citations

13.

Hosp, M, Alison M. Elliott, John G. Raynes, et al.. (1997). Neopterin, β2-Microglobulin, and Acute Phase Proteins in HIV-1-Seropositive and -Seronegative Zambian Patients with Tuberculosis. Lung. 175(4). 265–275. 28 indexed citations

14.

Zaknun, Daniela, et al.. (1997). Concurrent ganciclovir and foscarnet treatment for cytomegalovirus encephalitis and retinitis in an infant with acquired immunodeficiency syndrome: case report and review. The Pediatric Infectious Disease Journal. 16(8). 807–811. 8 indexed citations

15.

Diez‐Ruiz, Antonio, et al.. (1995). Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. European Journal Of Haematology. 54(1). 1–8. 263 indexed citations

16.

Ebenbichler, Christoph, Terry A. McNearney, Heribert Stoiber, et al.. (1995). Sera from HIV-1 infected individuals in all stages of disease preferentially recognize the V3 loop of the prototypic macrophage-tropic glycoprotein gp120 ADA. Molecular Immunology. 32(14-15). 1039–1045. 3 indexed citations

17.

Zangerle, Robert, Harald Gallati, Mario Sarcletti, Helmut Wächter, & Dietmar Fuchs. (1994). Tumor necrosis factor alpha and soluble tumor necrosis factor receptors in individuals with human immunodeficiency virus infection. Immunology Letters. 41(2-3). 229–234. 43 indexed citations

18.

Melichar, Bohuslav, Robert Zangerle, Erika Artner‐Dworzak, H. Wächter, & Dietmar Fuchs. (1993). Are Disturbances of Zinc Metabolism in Human Immunodeficiency Virus Type I (HIV-I) Infection Caused By Immune Activation?. Pteridines. 4(4). 195–199. 2 indexed citations

19.

Zangerle, Robert, Dietmar Fuchs, Gilbert Reibnegger, Peter Fritsch, & Helmut Wächter. (1991). Markers for disease progression in intravenous drug users infected with HIV-1. AIDS. 5(8). 985–992. 31 indexed citations

20.

Zangerle, Robert, Franz Allerberger, Peter Pohl, Peter Fritsch, & M P Dierich. (1991). High risk of developing toxoplasmic encephalitis in AIDS patients seropositive to Toxoplasma gondii. Medical Microbiology and Immunology. 180(2). 59–66. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact